Literature DB >> 3136022

On the structure of polymeric IgM.

A C Davis1, K H Roux, M J Shulman.   

Abstract

The cysteine at position 575 of the immunoglobulin mu heavy chain is thought to provide the only disulfide bonds joining the monomer subunits of mouse polymeric IgM. The importance of this cysteine in the assembly of polymeric IgM was investigated by using site-directed mutagenesis to produce mu chains with serine at position 575. Thirty percent of the secreted mutant IgM was covalently assembled polymer implying that cysteines other than Cys575 can form inter-subunit disulfide bonds. The polymeric IgM lacked J chain, mediated complement-dependent cytolysis and appeared to have a higher molecular weight than conventional IgM pentamers, as judged by sucrose gradient sedimentation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis mobility. Electron microscopy revealed that the mutant IgM molecule contained six subunits. Wild-type IgM, while synthesized predominantly as a pentameric molecule, was assembled in at least two other forms, which were distinguished by their electrophoretic mobility. The apparently higher molecular weight forms of wild-type IgM include hexameric molecules which, like the hexameric mutant IgM, contained much less J chain that the pentameric form and were 20-fold more efficient at activating complement-dependent cytolysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136022     DOI: 10.1002/eji.1830180705

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

1.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Homologous recombination in hybridoma cells: dependence on time and fragment length.

Authors:  M J Shulman; L Nissen; C Collins
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

3.  High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation.

Authors:  Roger Müller; Melissa A Gräwert; Thomas Kern; Tobias Madl; Jirka Peschek; Michael Sattler; Michael Groll; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

4.  Carbon nanotube atomic force microscopy tips: direct growth by chemical vapor deposition and application to high-resolution imaging.

Authors:  C L Cheung; J H Hafner; C M Lieber
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

5.  Influence of the mu-chain C-terminal sequence on polymerization of immunoglobulin M.

Authors:  A Getahun; M Lundqvist; D Middleton; G Warr; L Pilström
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

6.  The amino acid sequence of rabbit J chain in secretory immunoglobulin A.

Authors:  G J Hughes; S Frutiger; N Paquet; J C Jaton
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

7.  Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.

Authors:  S Martin; J M Casasnovas; D E Staunton; T A Springer
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Roles of heavy and light chains in IgM polymerization.

Authors:  K D Bornemann; J W Brewer; G B Beck-Engeser; R B Corley; I G Haas; H M Jäck
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.

Authors:  T D Randall; R M Parkhouse; R B Corley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

10.  Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM.

Authors:  Edward S X Moh; Chi-Hung Lin; Morten Thaysen-Andersen; Nicolle H Packer
Journal:  J Am Soc Mass Spectrom       Date:  2016-04-01       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.